Ian T. Meredith - Feb 17, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP Global Chief Med Officer
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 17, 2022
Transactions value $
-$28,696
Form type
4
Date filed
2/22/2022, 03:45 PM
Previous filing
Feb 17, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1.25K +3.95% $0.00 32.9K Feb 17, 2022 Direct F1
transaction BSX Common Stock Tax liability -$15.7K -367 -1.12% $42.83 32.5K Feb 17, 2022 Direct
transaction BSX Common Stock Options Exercise $0 +1.04K +3.19% $0.00 33.5K Feb 18, 2022 Direct F2
transaction BSX Common Stock Tax liability -$13K -305 -0.91% $42.55 33.2K Feb 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -1.25K -25% $0.00 3.75K Feb 17, 2022 Common Stock 1.25K Direct F1, F3
transaction BSX Deferred Stock Units Options Exercise $0 -1.04K -33.31% $0.00 2.08K Feb 18, 2022 Common Stock 1.04K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.